There are 3164 resources available
LBA66 - UpFrontPSMA: A randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel (D) versus docetaxel in metastatic hormone-sensitive prostate cancer (mHSPC)
Presenter: Arun Azad
Session: Proffered paper session: GU tumours, prostate
Resources:
Abstract
Slides
Webcast
CAR NK cells
Presenter: Katy Rezvani
Session: Gene modified T cells and new players
Resources:
Slides
Webcast
Personalised systemic approaches to improve survivorship and cure
Presenter: Yelena Janjigian
Session: Personalisation of surgical and systemic approaches in 2024: Optimising cure and quality of life in gastroesophageal cancer
Resources:
Slides
Webcast
Renal-cell carcinoma: Discussion
Presenter: Thomas Powles
Session: ESMO Clinical Practice Guidelines 2
Resources:
Slides
Webcast
Prognostic and predictive factors for clinical decision making
Presenter: Nadia Harbeck
Session: Incorporating novel treatment insights for ER+ early BC patients
Resources:
Slides
Webcast
Molecular characteristics in meningioma
Presenter: Felix Sahm
Session: Management and diagnostics of meningioma
Resources:
Webcast
Discussion
Session: YO Masterclass: Designing v2.0 clinical trials
Resources:
Webcast
Real world experience & patients' participation in multidisciplinary consortiums
Presenter: Bettina Ryll
Session: The future of cancer via patient expertise in research & innovation projects
Resources:
Slides
Webcast
The gut microbiota & immune related adverse events
Presenter: Christina Ruhlmann
Session: ESMO in collaboration with the MASCC: Shedding light on the hidden microbiota
Resources:
Slides
Webcast
LBA45 - Early switch from targeted to immunotherapy in advanced BRAFV600-positive melanoma: Long-term OS and final PFS results of the randomized phase II ImmunoCobiVem trial
Presenter: Dirk Schadendorf
Session: Mini oral session: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast